Oxygen Therapy Market to Reach USD 10.06 Billion by 2033 | CAGR 8.9% | North America Leads with 38% Share | Key Players: GE Healthcare, Inogen Inc., ICU Medical, ResMed, OMRON Healthcare

Oxygen Therapy Market Overview

The global oxygen therapy market reached US$ 4.69 billion in 2024 and is projected to grow to US$ 10.06 billion by 2033, expanding at a CAGR of 8.9% during the forecast period 2025-2033. The market plays a crucial role in the healthcare sector, providing life-sustaining treatment for patients with various respiratory and cardiovascular conditions. Oxygen therapy is primarily administered to increase oxygen saturation in the blood for individuals experiencing respiratory distress, chronic pulmonary disorders, or acute oxygen deficiency.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):-https://www.datamintelligence.com/download-sample/oxygen-therapy-market?Juli

The market's growth is driven by the rising prevalence of chronic respiratory diseases, such as chronic obstructive pulmonary disease (COPD), asthma, pneumonia, and sleep apnea, along with a growing geriatric population vulnerable to hypoxemia. According to the World Health Organization (WHO), respiratory illnesses remain among the top causes of mortality worldwide, reinforcing the need for advanced oxygen therapy solutions. Technological innovation is further fueling the market, with the introduction of portable oxygen concentrators (POCs), high-flow nasal cannulas, non-invasive ventilators, and smart oxygen delivery systems. These advancements are improving patient mobility, comfort, and adherence to therapy, particularly in homecare settings. Additionally, the increasing adoption of telehealth-enabled respiratory monitoring systems and government initiatives promoting home-based care are enhancing accessibility to oxygen therapy, especially in remote and aging populations.

Recent Developments

✅ January 2026: A major medical device manufacturer launched a next-generation portable oxygen concentrator with improved battery life, reduced weight, and smart connectivity features, enhancing mobility for homecare patients.

✅ November 2025: A leading respiratory care company introduced an AI-enabled oxygen delivery system that automatically adjusts flow rates based on real-time patient oxygen saturation levels.

✅ September 2025: A global healthcare technology firm expanded its high-flow nasal cannula portfolio with new models optimized for pediatric and neonatal care settings.

✅ June 2025: A prominent respiratory solutions provider partnered with a telehealth platform to offer remote oxygen therapy monitoring and analytics, enabling clinicians to track therapy adherence and patient outcomes virtually.

✅ March 2025: A consortium of hospitals and medical device makers launched a pilot program deploying portable oxygen units with integrated pulse oximeters to improve oxygen therapy management for patients with chronic respiratory conditions.

Mergers & Acquisitions

✅ January 2026: A leading medical device conglomerate acquired a specialized oxygen therapy solutions provider, enhancing its portfolio of portable oxygen concentrators, masks, and high-flow systems for both clinical and homecare settings.

✅ October 2025: A global respiratory care specialist merged with an AI-enabled respiratory monitoring startup, strengthening its capabilities in intelligent oxygen delivery and remote patient management technologies.

✅ August 2025: An international healthcare technology company completed the acquisition of a portable oxygen concentrator developer, expanding its reach in the fast-growing home oxygen therapy market.

✅ May 2025: A major medical equipment manufacturer acquired a high-flow nasal cannula and ventilator accessories firm, broadening its respiratory product offerings to serve acute care and chronic disease segments.

✅ March 2025: A strategic merger between two mid-sized respiratory device firms created a unified platform focused on integrated oxygen therapy systems, telehealth connectivity, and next-generation wearable oxygen delivery devices.

Buy Now & Unlock 360° Market Intelligence:-https://www.datamintelligence.com/buy-now-page?report=oxygen-therapy-market?Juli

Key Players:
GE Healthcare | Inogen, Inc. | ICU Medical, Inc. | ResMed | OMRON Healthcare | HERSILL S.L. | Koninklijke Philips N.V. | Drägerwerk AG & Co. KGaA | CAIRE Inc. | Rhythm Healthcare, LLC

Key Highlights:

GE Healthcare - Major supplier of advanced oxygen therapy systems, including portable and hospital-based oxygen delivery devices.

Inogen, Inc. - Specializes in portable oxygen concentrators for homecare and mobility applications.

ICU Medical, Inc. - Provides critical care oxygen delivery systems and accessories for hospitals and emergency care.

ResMed - Focused on respiratory care and connected devices, including oxygen therapy solutions integrated with remote patient monitoring.

OMRON Healthcare - Offers oxygen concentrators and therapy devices for chronic respiratory disease management.

HERSILL S.L. - Supplies hospital-grade oxygen delivery systems, focusing on high reliability and safety.

Koninklijke Philips N.V. - Provides comprehensive oxygen therapy solutions, including portable concentrators and high-flow devices.

Drägerwerk AG & Co. KGaA - Specializes in critical care and acute oxygen therapy systems for hospital applications.

CAIRE Inc. - Global leader in portable and stationary oxygen concentrators, catering to homecare and clinical environments.

Rhythm Healthcare, LLC - Focused on innovative oxygen therapy devices for patients with chronic respiratory conditions.

Market Segmentation:

By Product:

Oxygen Source Equipment - Devices generating oxygen from ambient air for hospital and homecare applications.

Oxygen Concentrators - Portable and stationary concentrators used for continuous oxygen supply at home or clinical settings.

Oxygen Cylinders - Compressed oxygen cylinders for emergency, ambulatory, and clinical use.

Liquid Oxygen Tanks - High-capacity liquid oxygen storage tanks for hospitals and long-term care facilities.

Others - Accessories, masks, nasal cannulas, and high-flow oxygen delivery systems.

By Application:

Chronic Obstructive Pulmonary Disease (COPD) - Major application driving demand due to increasing prevalence worldwide.

Asthma - Oxygen therapy used to relieve severe asthma attacks and maintain oxygen saturation.

Obstructive Sleep Apnea (OSA) - Oxygen support combined with CPAP or BiPAP therapy for sleep apnea patients.

Pneumonia - Oxygen therapy essential for severe respiratory infections and hospitalized patients.

Others - Pulmonary fibrosis, cystic fibrosis, hypoxemia, and other respiratory disorders.

By End-User:

Hospitals and Clinics - Largest segment, driven by acute respiratory care and ICU requirements.

Home Healthcare - Growing rapidly due to portable oxygen concentrators and aging population with chronic respiratory conditions.

Speak to Our Analyst and Get Customization in the report as per your requirements:-https://www.datamintelligence.com/customize/oxygen-therapy-market?Juli

Regional Insights

North America (38% market share)
North America dominates the global oxygen therapy market, driven by the high prevalence of chronic respiratory diseases, advanced healthcare infrastructure, and strong adoption of home healthcare services. The U.S. leads the region due to widespread use of portable oxygen concentrators and government reimbursement programs for home oxygen therapy. Canada also contributes significantly, with increasing awareness of respiratory health and an aging population.

Europe (27% market share)
Europe holds a substantial share of the market, supported by well-established healthcare systems and rising investments in advanced respiratory care solutions. Countries like Germany, France, and the U.K. show strong adoption of oxygen therapy in hospitals and homecare settings. The region is also witnessing growing use of portable and high-flow oxygen therapy devices.

Asia-Pacific (23% market share)
Asia-Pacific is the fastest-growing market due to rising incidences of chronic respiratory conditions, increasing industrial pollution, and expanding healthcare infrastructure. China and India are key markets, benefiting from government initiatives to improve respiratory healthcare and growing awareness of home-based oxygen therapy. Japan and South Korea also contribute with advanced medical technology adoption.

Market Dynamics

Driver:
Technological innovations are significantly propelling the growth of the oxygen therapy market by improving efficiency, comfort, and accessibility of oxygen delivery systems. Advanced devices enhance patient outcomes, expand therapeutic applications, and make therapy more convenient in hospitals and homecare settings.

Portable oxygen concentrators, such as the Inogen One G4 and Philips Respironics SimplyGo, have transformed home oxygen therapy by enabling patients with chronic respiratory diseases like COPD and asthma to maintain mobility and independence.

Example: In April 2025, Philips Respironics launched the Simply Go Mini, an FDA-approved ultra-portable oxygen concentrator weighing just 2.3 kg (5 lbs). Designed for active users, it allows seamless integration into daily routines, including commuting, shopping, or traveling, thereby increasing adoption among homecare patients.

Restraint:
Despite rapid advancements, certain technical limitations continue to restrain market growth and affect widespread adoption, particularly in regions with limited healthcare resources.

Portable oxygen concentrators often struggle to meet high oxygen flow requirements, limiting their use for patients with severe respiratory conditions such as acute COPD, pneumonia, or acute respiratory distress syndrome. For instance, devices like the Inogen One G3 and Philips SimplyGo are suitable for mild to moderate conditions but may underperform in critical care scenarios.

📌 Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription

☛ Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape

✅ Sustainability Impact Analysis

✅ KOL / Stakeholder Insights

✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots

✅ Market Volatility & Emerging Risks Analysis

✅ Quarterly Industry Report Updated

✅ Live Market & Pricing Trends

✅ Import-Export Data Monitoring
☛ Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?Juli

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.